Biora Therapeutics
PrivateLast Round
Bankruptcy
Feb 19, 2025
Total Funding Raised
$326.03M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Biora Therapeutics (NAS: BIOR) is a biotechnology company focused on developing innovative oral biotherapeutics that enhance therapeutic delivery for gastrointestinal diseases and provide needle-free, oral alternatives for systemic biotherapeutics.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Medical Devices, Clinical Trials
Business Model
B2B2C
Customer Profile
Revenue Share
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Biora Therapeutics Comparables
Compare Biora Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Rani Therapeutics | 86% | |
| Biograil | 84% | |
| Oramed Pharmaceuticals Inc. | 82% |
Biora Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Bankruptcy | Feb 19, 2025 | ||||
| Follow-on Offering | Oct 29, 2024 | ||||
| Debt | Aug 12, 2024 | ||||
| Follow-on Offering | Apr 3, 2024 | ||||
| Follow-on Offering | Aug 19, 2021 | ||||
Private Placement | Jun 10, 2021 |
Biora Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| H.C. Wainwright & Co. | Follow-on Offering |
| Davidson Kempner Capital Management | Bankruptcy |
| Wells Fargo Securities, LLC | Follow-on Offering, IPO |
| Athyrium Capital Management | Convertible Debt, Series A, Series B |
| Context Capital Management | Bankruptcy |
| Highbridge Capital Management | Bankruptcy |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 21, 2026
Monthly visitors increased 46% MoM, reaching 2.6K.
- Jul 25, 2026
Monthly visitors increased 75% MoM.
Biora Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Biora Therapeutics's valuation, stock price, and market status.
Is Biora Therapeutics a public or private company?
Biora Therapeutics is a private company.
What is the current stock price of Biora Therapeutics?
Biora Therapeutics is a private company, so its shares have no public market price. Caplight tracks Biora Therapeutics's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Biora Therapeutics worth (valuation)?
Valuation information for Biora Therapeutics is not publicly available.
Can I buy Biora Therapeutics stock?
Biora Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Biora Therapeutics's last funding round?
Biora Therapeutics's most recent funding round was Bankruptcy on February 19, 2025.
Who are the main investors in Biora Therapeutics?
Key investors in Biora Therapeutics include H.C. Wainwright & Co., Wells Fargo Securities, LLC, Athyrium Capital Management.
Will Biora Therapeutics IPO soon?
No public IPO plans have been announced for Biora Therapeutics.
How can I track Biora Therapeutics secondary market activity?
Caplight tracks bids, offers, and trades in Biora Therapeutics's shares on secondary markets.